GATA1 Mutation In Transient Leukemia (TL) and Myeloid Leukemia of Down Syndrome

GATA1 Mutation In Transient Leukemia (TL) and Myeloid Leukemia of Down Syndrome

Show other versions (1)

Detalhes bibliográficos
Main Authors:	Reinhardt, K, Kate, A, Bohmer, K, Vyas, P, Dirk, R
Formato:	Conference item
Publicado em:	2010

Registos relacionados

GATA1 Mutation In Transient Leukemia (TL) and Myeloid Leukemia of Down Syndrome
Por: Reinhardt, K, et al.
Publicado em: (2010)

Analysis of GATA1 mutations in Down syndrome transient myeloproliferative disorder and myeloid leukemia.
Por: Alford, K, et al.
Publicado em: (2011)

GATA1s induces hyperproliferation of eosinophil precursors in Down syndrome transient leukemia
Por: Maroz, A, et al.
Publicado em: (2014)

GATA1s induces hyperproliferation of eosinophil precursors in Down syndrome transient leukemia.
Por: Maroz, A, et al.
Publicado em: (2014)

Myeloid pre-leukemia and leukemia of Down syndrome
Por: Cruz Hernandez, D, et al.
Publicado em: (2020)

GATA1 and cooperating mutations in myeloid leukaemia of Down syndrome
Por: Garnett, C, et al.
Publicado em: (2019)

Acute leukemias in children with Down syndrome.
Por: Zwaan, C, et al.
Publicado em: (2010)

Acute leukemias in children with Down syndrome.
Por: Zwaan, M, et al.
Publicado em: (2008)

Myeloid leukemia in children 4 years or older with Down syndrome often lacks GATA1 mutation and cytogenetics and risk of relapse are more akin to sporadic AML.
Por: Hasle, H, et al.
Publicado em: (2008)

Sensitive, rapid diagnostic test for transient abnormal myelopoiesis and myeloid leukemia of Down syndrome
Por: Cruz Hernandez, D, et al.
Publicado em: (2020)

Mechanisms of progression of myeloid preleukemia to transformed myeloid leukemia in children with Down syndrome
Por: Labuhn, M, et al.
Publicado em: (2019)

JAK mutations in Down syndrome - associated transient myeloproliferative disorder and acute megakaryocytic leukemia
Por: Vyas, P, et al.
Publicado em: (2008)

GATA1 mutation analysis demonstrates two distinct primary leukemias in a child with down syndrome; implications for leukemogenesis.
Por: Hellebostad, M, et al.
Publicado em: (2005)

Down syndrome preleukemia and leukemia.
Por: Maloney, K, et al.
Publicado em: (2014)

Analysis of JAK3, JAK2, and C-MPL mutations in transient myeloproliferative disorder and myeloid leukemia of Down syndrome blasts in children with Down syndrome.
Por: Norton, A, et al.
Publicado em: (2007)

Molecular insights into Down syndrome-associated leukemia.
Por: Vyas, P, et al.
Publicado em: (2007)

Natural history of GATA-1 mutations in Down syndrome.
Por: Ahmed, M, et al.
Publicado em: (2003)

Abnormalities in the myeloid progenitor compartment in Down syndrome fetal liver precede acquisition of GATA1 mutations.
Por: Tunstall-Pedoe, O, et al.
Publicado em: (2008)

Natural history of GATA1 mutations in Down syndrome.
Por: Ahmed, M, et al.
Publicado em: (2004)

GATA1-mutant clones are frequent and often unsuspected in babies with Down syndrome: identification of a population at risk of leukemia.
Por: Roberts, I, et al.
Publicado em: (2013)

Heterogeneous leukemia stem cells in myeloid blast phase chronic myeloid leukemia
Por: Kinstrie, R, et al.
Publicado em: (2016)

Frequent Mutation of the Polycomb-Associated Gene ASXL1 In Acute Myeloid Leukemia Secondary to Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
Por: Fernandez-Mercado, M, et al.
Publicado em: (2010)

Recurrent ETNK1 mutations in atypical chronic myeloid leukemia.
Por: Gambacorti-Passerini, C, et al.
Publicado em: (2015)

Analysis of GATA-1 mutations in chronic myeloid leukaemia.
Por: Halsey, C, et al.
Publicado em: (2006)

Recurrent SETBP1 mutations in atypical chronic myeloid leukemia
Por: Piazza, R, et al.
Publicado em: (2013)

Recurrent SETBP1 mutations in atypical chronic myeloid leukemia.
Por: Piazza, R, et al.
Publicado em: (2013)

GATA1 mutational analysis in chronic myeloid leukaemia.
Por: Halsey, C, et al.
Publicado em: (2007)

Mutations in PTPN11 are rare in adult myelodysplastic syndromes and acute myeloid leukemia.
Por: Watkins, F, et al.
Publicado em: (2004)

Severe TMD/AMKL with GATA1 mutation in a stillborn fetus with Down syndrome.
Por: Heald, B, et al.
Publicado em: (2007)

Frequent mutation of the polycomb-associated gene ASXL1 in the myelodysplastic syndromes and in acute myeloid leukemia.
Por: Boultwood, J, et al.
Publicado em: (2010)

An overview of targeted therapies in acute myeloid leukemia
Por: Turkalj, S, et al.
Publicado em: (2023)

Autophagy in the pathogenesis of myelodysplastic syndrome and acute myeloid leukemia.
Por: Watson, A, et al.
Publicado em: (2011)

Mutational analysis of disease relapse in patients allografted for acute myeloid leukemia
Por: Quek, L, et al.
Publicado em: (2016)

TP53-mutated myelodysplastic syndrome and acute myeloid leukemia: biology, current therapy, and future directions
Por: Daver, NG, et al.
Publicado em: (2022)

Modelling the progression of a preleukemic stage to overt leukemia in children with down syndrome
Por: Labuhn, M, et al.
Publicado em: (2018)

Assessment of minimal residual disease in acute myeloid leukemia.
Por: Grimwade, D, et al.
Publicado em: (2010)

Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia.
Por: Vyas, P, et al.
Publicado em: (2015)

Myelodysplastic syndrome due to somatic GATA1 mutation.
Por: Freson, K, et al.
Publicado em: (2004)

Autophagy in hematopoiesis and acute myeloid leukemia
Por: Watson, A
Publicado em: (2014)

Coexistence of LMPP-like and GMP-like leukemia stem cells in acute myeloid leukemia.
Por: Goardon, N, et al.
Publicado em: (2011)